About Malvyn Pharmaceuticals Private Limited
Data last updated:
Malvyn Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33301UP2016PTC082585. Its GSTIN is 09AAKCM2690R1ZJ (Uttar Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Suresh Chandra Mishra and Harsh Rajprakash Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 138/11C Chota Bhagara, Allahabad, Uttar Pradesh, India – 211003.
As per the financials filed for FY 2024, the company reported a revenue of ₹75.98 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹4.63 Lakh (net margin -6.1%) and EBITDA of -₹4.25 Lakh (EBITDA margin -5.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.
The company is associated with 1 brand: Malvyn.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website malvynpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address138/11C Chota Bhagara, Allahabad, Uttar Pradesh, India – 211003
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Malvyn Pharmaceuticals Private Limited
The main business activity of Malvyn Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Malvyn Pharmaceuticals Private Limited FY 2025 filings available
Malvyn Pharmaceuticals Private Limited reported revenue of ₹75.98 Lakh (down 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Malvyn Pharmaceuticals Private Limited
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Malvyn Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹4.25 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.63 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Malvyn Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -6.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Malvyn Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vasphar Pharmaceuticals Private Limited | ₹76.88 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Kaithal, Haryana, India |
| Zwitt Pharmaceuticals Private Limited | ₹76.81 Lakh (FY 2025) | •••• | •••• | 141.0% | •••• | Ahmedabad, Gujarat, India |
| Salsburg Pharmaceuticals Private Limited | ₹76.8 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Micropan Pharmaceuticals Private Limited | ₹76.72 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Thane, Maharashtra, India |
| Laissez Faire Pharmaceuticals Private Limited | ₹76.58 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Chandigarh, India |
| Malvyn Pharmaceuticals Private Limited this company | ₹75.98 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Allahabad, Uttar Pradesh, India |
| Bharavi Pharmaceuticals Limited | ₹75.7 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Vadodara, Gujarat, India |
| Mahakailasha Pharmaceuticals Private Limited | ₹75.61 Lakh (FY 2024) | •••• | •••• | 149.0% | •••• | Uttar Pradesh, India |
| NT Pathogens Pharmaceuticals Private Limited | ₹75.48 Lakh (FY 2024) | •••• | •••• | 23.0% | •••• | Indore, Madhya Pradesh, India |
| Camphor Pharmaceuticals Private Limited | ₹75.28 Lakh (FY 2025) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Rhuto India Pharmaceuticals Private Limited | ₹75.24 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Malvyn Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals Private Limited is audited by AGRAWAL SACHIN & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AGRAWAL SACHIN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Chandra Mishra | Director | 07 Apr 2016 | 10 Years 6 Months | Current |
| Harsh Rajprakash Mishra | Additional Director | 13 Aug 2019 | 7 Years 1 Months | Current |
| Rajprakash Srinarayan Mishra | Additional Director | 10 Mar 2022 | 4 Years 6 Months | Current |
Ownership and Shareholding of Malvyn Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals operates one associated brand: Malvyn. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Malvyn focuses on specialty pharmaceuticals, including DMARDs, pain management, and nutritionals. | malvynpharmaceuticals.com |
Employees and EPFO Compliance at Malvyn Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Malvyn Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Rajprakash Srinarayan Mishra was appointed as Additional Director on 10 Mar 2022.
Credit Ratings, Litigation & Regulatory Alerts for Malvyn Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Malvyn Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Malvyn Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCM2690R1ZJ | Uttar Pradesh | Active | 29 Jun 2017 |
| 27AAKCM2690R1ZL | Maharashtra | Active | 18 Nov 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Malvyn Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Malvyn Pharmaceuticals Private Limited
Malvyn Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 April 2016 (10+ years old) and is registered under CIN U33301UP2016PTC082585.
Malvyn Pharmaceuticals reported revenue of ₹75.98 Lakh for FY 2024 (down 3% YoY).
Malvyn Pharmaceuticals has 3 current directors:
- Suresh Chandra Mishra - Director
- Harsh Rajprakash Mishra - Additional Director
- Rajprakash Srinarayan Mishra - Additional Director
Malvyn Pharmaceuticals reported a net loss of ₹4.63 Lakh (net margin -6.1%) and EBITDA of -₹4.25 Lakh (EBITDA margin -5.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Malvyn Pharmaceuticals is 11% over three years and 4% over five years. In the latest year (FY 2024) revenue fell 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Malvyn Pharmaceuticals is 09AAKCM2690R1ZJ, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAKCM2690R1ZL (Maharashtra).
The CIN (Corporate Identification Number) of Malvyn Pharmaceuticals is U33301UP2016PTC082585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Malvyn Pharmaceuticals was incorporated on 07 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Malvyn Pharmaceuticals by revenue are Vasphar Pharmaceuticals Private Limited, Zwitt Pharmaceuticals Private Limited, Salsburg Pharmaceuticals Private Limited, Micropan Pharmaceuticals Private Limited, Laissez Faire Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rajprakash Srinarayan Mishra was appointed as Additional Director on 10 Mar 2022. Harsh Rajprakash Mishra was appointed as Additional Director on 13 Aug 2019. Suresh Chandra Mishra was appointed as Director on 07 Apr 2016.
Malvyn Pharmaceuticals can be reached through the website malvynpharmaceuticals.com. Its registered office is in Allahabad, Uttar Pradesh, India.